Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Korean scientists divulge new amide compounds for treatment of bone disorders

Dec. 16, 2010

MHRA accepts BioMarin's application for phase III GALNS trial in MPS IVA

Dec. 15, 2010

FDA approves clinical development plan for Menerba

Dec. 14, 2010

Spherix presents data from phase II trial of D-tagatose

Dec. 14, 2010

Galapagos completes first-in-human study of GLPG-0492 in cachexia

Dec. 10, 2010

FDA committee recommends approval of obesity treatment Contrave

Dec. 10, 2010

Merck & Co. describes new somatostatin sst5 receptor antagonists

Dec. 9, 2010

Prochieve 8% reduces incidence of preterm birth in phase III study

Dec. 7, 2010

Forest Laboratories discloses novel acetyl-CoA carboxylase inhibitors

Dec. 7, 2010

Case Western Reserve University licenses insulin analogues to Thermalin Diabetes

Dec. 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...